Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MICHAEL GILBERT MARCUS

Allopathic & Osteopathic Physicians Pediatrics Pediatric Allergy/Immunology

NPI
1134114192
CMS profile
323731
Location
BROOKLYN, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$145,154.55

156 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $130,197.24 123
Amgen Inc. $5,642.28 6
Regeneron Healthcare Solutions, Inc. $3,946.52 9
Regeneron Pharmaceuticals, Inc. $3,255.00 1
Genentech USA, Inc. $1,802.99 2
Covis Pharma GmBH $152.54 7
Novartis Pharmaceuticals Corporation $60.90 3
GENZYME CORPORATION $39.66 2
Sobi, Inc $39.23 2
Optinose US, Inc. $18.19 1

Page 2 of 4; records 51–100 of 156 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MICHAEL GILBERT MARCUS

NPI 1134114192 · CMS profile ID 323731

Allopathic & Osteopathic Physicians / Pediatrics / Pediatric Allergy/Immunology

BROOKLYN, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 156 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1134114192?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MICHAEL GILBERT MARCUS, NPI 1134114192, CMS profile ID 323731. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 156 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1134114192?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). MICHAEL GILBERT MARCUS, NPI 1134114192, CMS profile ID 323731. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 156 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1134114192?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
MICHAEL GILBERT MARCUS, NPI 1134114192, CMS profile ID 323731, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 156 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1134114192?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

156 matching records · $145,154.55 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 156 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 156.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $2,150.0011/03/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829527413 CMS
AstraZeneca Pharmaceuticals LP $1,050.0011/02/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829373617 CMS
AstraZeneca Pharmaceuticals LP $1,050.0011/02/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829880289 CMS
AstraZeneca Pharmaceuticals LP $3,750.0011/02/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829951399 CMS
AstraZeneca Pharmaceuticals LP $2,150.0011/02/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830097913 CMS
Novartis Pharmaceuticals Corporation $19.3111/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813055535 CMS
Regeneron Healthcare Solutions, Inc. $2,153.0011/02/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 809602507 CMS
AstraZeneca Pharmaceuticals LP $1,611.0010/31/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829362755 CMS
AstraZeneca Pharmaceuticals LP $125.0010/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829963921 CMS
AstraZeneca Pharmaceuticals LP $51.8310/28/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830013509 CMS
AstraZeneca Pharmaceuticals LP $125.0010/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829499901 CMS
AstraZeneca Pharmaceuticals LP $32.3110/27/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829976093 CMS
Regeneron Healthcare Solutions, Inc. $125.0010/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 809602505 CMS
AstraZeneca Pharmaceuticals LP $275.5210/20/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829468385 CMS
Covis Pharma GmBH $16.4410/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844400427 CMS
Covis Pharma GmBH $16.4410/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 847689257 CMS
AstraZeneca Pharmaceuticals LP $3,750.0010/12/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829753689 CMS
AstraZeneca Pharmaceuticals LP $3,200.0010/12/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829815323 CMS
Regeneron Healthcare Solutions, Inc. $15.0510/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 809602503 CMS
Regeneron Pharmaceuticals, Inc. $3,255.0010/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 809681501 CMS
AstraZeneca Pharmaceuticals LP $124.9810/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829625465 CMS
AstraZeneca Pharmaceuticals LP $125.0010/06/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829979633 CMS
AstraZeneca Pharmaceuticals LP $67.7710/06/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830058315 CMS
AstraZeneca Pharmaceuticals LP $125.0010/06/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830081971 CMS
AstraZeneca Pharmaceuticals LP $350.0010/03/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829466455 CMS
AstraZeneca Pharmaceuticals LP $145.3210/03/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829846901 CMS
AstraZeneca Pharmaceuticals LP $133.8110/03/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829852385 CMS
Novartis Pharmaceuticals Corporation $23.1309/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813055531 CMS
GENZYME CORPORATION $15.9609/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843472677 CMS
AstraZeneca Pharmaceuticals LP $15.9209/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830055399 CMS
AstraZeneca Pharmaceuticals LP $1,050.0009/08/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829741743 CMS
AstraZeneca Pharmaceuticals LP $4,300.0009/01/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829831587 CMS
Regeneron Healthcare Solutions, Inc. $16.0708/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 809602501 CMS
AstraZeneca Pharmaceuticals LP $4,300.0008/25/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829356027 CMS
AstraZeneca Pharmaceuticals LP $3,750.0008/25/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829397471 CMS
AstraZeneca Pharmaceuticals LP $302.6308/24/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829845303 CMS
AstraZeneca Pharmaceuticals LP $197.4208/24/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830016691 CMS
AstraZeneca Pharmaceuticals LP $124.9808/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830041603 CMS
AstraZeneca Pharmaceuticals LP $15.6108/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830049981 CMS
AstraZeneca Pharmaceuticals LP $305.1108/24/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830053235 CMS
Regeneron Healthcare Solutions, Inc. $1,435.0008/24/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 809602499 CMS
AstraZeneca Pharmaceuticals LP $2,150.0008/17/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829790287 CMS
AstraZeneca Pharmaceuticals LP $114.5808/17/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829853087 CMS
AstraZeneca Pharmaceuticals LP $97.8108/16/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829372561 CMS
AstraZeneca Pharmaceuticals LP $777.0308/16/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829389411 CMS
AstraZeneca Pharmaceuticals LP $187.9908/16/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829633087 CMS
AstraZeneca Pharmaceuticals LP $116.3808/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829634513 CMS
AstraZeneca Pharmaceuticals LP $60.6708/12/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829890531 CMS
AstraZeneca Pharmaceuticals LP $118.7408/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830215677 CMS
AstraZeneca Pharmaceuticals LP $4,296.0008/10/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829586269 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $204,516.61 263
PY2020 $75,583.51 72
PY2021 $145,154.55 156
PY2022 $214,586.70 242
PY2023 $224,414.03 254
PY2024 $198,568.46 208
PY2025 $247,963.04 228

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2019 Recipient $10,911.98 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient AstraZeneca Pharmaceuticals LP $540.98 12/31/2019 Covered Recipient Physician A Phase 2/3 Randomized, Double-blind, Palivizumab-controlled Study to Evaluate the Safety of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in High-risk Children (MEDLEY). No dispute reported 06/30/2026 685005911
Recipient AstraZeneca Pharmaceuticals LP $7,371.00 09/04/2019 Covered Recipient Physician A Phase 2/3 Randomized, Double-blind, Palivizumab-controlled Study to Evaluate the Safety of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in High-risk Children (MEDLEY). No dispute reported 06/30/2026 685005909
Recipient AstraZeneca AB $3,000.00 02/08/2019 Covered Recipient Physician A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma. No dispute reported 06/30/2026 685006027